|Day Low/High||13.45 / 15.67|
|52 Wk Low/High||2.54 / 18.38|
The companies that staked a flag in the state for the medical program were in a great position to quickly hit the ground running.
I'm focused on stock picking and continue to hunt for more sector plays.
Aurinia Pharma has some positive catalysts, and I am taking partial gains in cannabis names as they remain strong.
Aphria investors will have a larger stake in the combined company post-merger.
I am watching names like Curaleaf and the MSOS cannabis ETF, which could keep moving higher.
It has been a challenging road for these firms, but now it appears that positive things are about to happen.
Companies are adding capacity and outlets to take advantage of voters' decision this week to legalize adult-use cannabis.
The potential of legal New York adult-use cannabis sales have been estimated at $1.5 billion a year by 2023.
Cannabis investors are keenly aware of the landscape and how it could play out for the industry.
This is a very healthy market and some consolidations and pullbacks would be advantageous for trading.
Only five companies went public during the first half of 2020 versus 13 in the first half of 2019.
Don't be in a rush. The key to accumulating stocks in this environment is to move incrementally.
It requires some increased emphasis on defense just in case it develops into something more significant.
How is Trulieve accomplishing what so many other cannabis companies have attempted and failed?
My focus remains on individual stock picking. The market timers are being crushed again.
State's dispensaries get OK to reopen recreational curbside service on May 25.
Last week's "Trade of the Week" -- a basket of speculative cannabis stocks -- was intended, as I wrote, through the end of the year. In looking at the buy levels, it was a very successful idea -- with three of the stocks rising by more than 20% as ...
Here is your Marijuana Moment. Last week, my Trade of the Week (and a half!) was a basket of cannabis stocks -- and I moved to large sized in all of them during the week (Note: The stocks started to roll higher on Friday): My package includes ($7.0...
As related to my year end cannabis play (and the possible "January Effect"), (+7%) and (+5%) are getting a bit jiggy after the long fall lower in 2019.
* My package includes ($7.00), ($5.69), ($5.45), ($2.25) and ($8.15) * It is likely that the maximum tax selling pressure is now virtually over * While technically "The Trade of the Week" - this is my favorite group to benefit from the "January Effe...
* In the hope for a "January Effect" after tax loss selling in December I added to ($7.82), ($6.70), ($5.90), ($5.29) and ($2.19) today.
If you want to find cheap stocks with great potential to rebound in 2020, the best place to look is marijuana names.
* Let's get "Chai!" A pet peeve I have is that many talking heads don't update their investment ideas on an ongoing basis. I try to be transparent and honest about my winners and losers, and to further improve my own transparency/accountability I am...
Morningstar Magazine offers insight into future growth potential for cannabis industry and stocks.
I don't want there to be any ambiguity about the size of my positions or about my buy and short levels as I strive for as much transparency as possible. "When the time comes to buy, you won't want to." - Walter Deemer "When the time comes to sell, y...